✦ LIBER ✦

Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone

✍ Scribed by Bochtler, Tilmann; Hegenbart, Ute; Kunz, Christina; Benner, Axel; Seckinger, Anja; Dietrich, Sascha; Granzow, Martin; Neben, Kai; Goldschmidt, Hartmut; Ho, Anthony D.; Hose, Dirk; Jauch, Anna; Schönland, Stefan O.

Book ID: 125538196
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 485 KB
Volume: 21
Category: Article
ISSN: 1350-6129
DOI: 10.3109/13506129.2013.854766

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gain of 1q21 Is an Unfavorable Genetic P

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

✍ Pavel Nemec; Zuzana Zemanova; Henrieta Greslikova; Kyra Michalova; Hana Filkova; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 163 KB

1p21 deletions are strongly associated w

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Chang, H; Qi, X; Jiang, A; Xu, W; Young, T; Reece, D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

1p21 deletions are strongly associated w

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Chang, H; Qi, X; Jiang, A; Xu, W; Trieu, Y; Reece, D 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB